IndraLab

Statements


| 2

eidos
"Regorafenib downregulates c-FOS expression , resulting in the suppression of AP-1 activation , which is occasionally seen in sorafenib-resistant HCC [ 9,10 ] ."

eidos
"Interestingly , regorafenib downregulated c-FOS expression , resulting in the suppression of AP-1 activation , which is occasionally seen in sorafenib-resistant HCC [ 9,10 ] ."